Achievement of diabetes treatment goals in Mexico from 2016-2022: A retrospective analysis of nationally representative surveys
Ramirez-Garcia, D.; Mendez-Labra, P. N.; Fermin-Martinez, C. A.; Perezalonso-Espinosa, J.; Diaz-Sanchez, J. P.; Paz-Cabrera, C. D.; Vargas-Vazquez, A.; Antonio-Villa, N. E.; Seiglie, J. A.; Danaei, G.; Bello-Chavolla, O. Y.
Show abstract
BACKGROUNDEffective cardiovascular disease (CVD) risk management is a cornerstone of optimal diabetes care. Here, we estimated the prevalence and determinants of CVD risk factor control amongst individuals with diagnosed diabetes in Mexico. METHODSWe analyzed data from individuals with diagnosed diabetes [≥]20 years from the 2016-2023 Mexican National Health and Nutrition Surveys. We estimated the prevalence of glycemic, blood pressure (BP), non-current smoking, and combined CVD risk factor control. LDL-C control was assessed using SCORE2-Diabetes risk categories. We estimated the prevalence of BP-lowering, cholesterol-lowering, and glucose-lowering medication use, and explored determinants of control achievement using logistic regression. RESULTSWe analyzed data representing 43.2 million adults with diagnosed diabetes during 2016-2023. In 2023, glycemic control was 29% (95%CI 21%-38%), BP control 22.9% (95%CI 14%-31%), and non-current smoking 89% (95%CI 81%-96%). The proportion of people classified as high or very-high CVD risk increased from 59.8% (95%CI 52.1%-67.0%) in 2016 to 68.4% (95%CI 55.6%-78.9%) in 2023, representing [~]5.1 million adults. LDL-C control prevalence increased from 2.8% (95%CI 1.2%-4.4%) in 2016 to 6.6% (95%CI 1.9%-11.2%) in 2023. Combined risk factor control achievement was low primarily due to suboptimal LDL-C control, despite high medication use; this was more likely achieved in females, younger individuals, and those with college education or living in states with higher socioeconomic position. CONCLUSIONSDespite increasing CVD risk during this period, comprehensive glycemic and CVD risk factor management for adults with diabetes in Mexico remains suboptimal. Our findings highlight the need for strategies to address gaps in CVD risk management to reduce premature mortality in this population. Lay summaryThis study examined how well adults with diabetes in Mexico are controlling key risk factors for cardiovascular disease, such as blood glucose levels, blood pressure, smoking, and cholesterol levels. Authors used nationally representative surveys from 2016-2023 analyzing data which represents over 43.2 million adults living with diagnosed diabetes. O_LIIn 2023, fewer than one-third of individuals with diabetes had adequate blood glucose control, and fewer than one in ten met recommended cholesterol targets, despite high rates of medication use. Cardiovascular risk increased for those at the highest risk by nearly 9% between 2016 and 2023. C_LIO_LIBetter control of these risk factors was more common among women, younger individuals, those with higher education, and those living in more socioeconomically advantaged areas. C_LI GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=81 SRC="FIGDIR/small/24313926v2_ufig1.gif" ALT="Figure 1"> View larger version (39K): org.highwire.dtl.DTLVardef@66e47dorg.highwire.dtl.DTLVardef@122fd03org.highwire.dtl.DTLVardef@10f992org.highwire.dtl.DTLVardef@71094f_HPS_FORMAT_FIGEXP M_FIG C_FIG
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Vitamin B12 and Risk of Diabetes: New insight from Cross-Sectional and Longitudinal Analyses of the China Stroke Primary Prevention Trial (CSPPT) 94%
- A plasma metabolite score of three eicosanoids predicts incident type 2 diabetes – a prospective study in three independent cohorts 93%
- Predictors of Arterial Stiffness in Adolescents and Adults with Type 1 Diabetes: A Cross-Sectional Study 92%
Similar papers in this journal
- Covid-19 fatality prediction in people with diabetes and prediabetes using a simple score at hospital admission 94%
- Heterogeneity of Treatment Effects Across Nine Glucose-Lowering Drug Classes in Type 2 Diabetes: Extension of the LEGEND-T2DM Network Study 93%
- Use of semaglutide and risk of non-arteritic anterior ischemic optic neuropathy: A Danish-Norwegian cohort study 92%
Similar papers in this journal
- Diabetes-related excess mortality in Mexico: a comparative analysis of national death registries between 2017-2019 and 2020 95%
- Poor in-utero growth, reduced beta cell secretion and high plasma glucose in childhood are harbingers of glucose intolerance in young Indians 93%
- Metabolome-defined obesity and the risk of future diabetes and mortality 92%
Similar papers in this journal
- Replication and cross-validation of T2D subtypes based on clinical variables: an IMI-RHAPSODY study 93%
- Role of Weight Loss Induced Prediabetes Remission in the Prevention of Type 2 Diabetes – Time to Improve Diabetes Prevention 93%
- Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: an overview of the data from the epidemiological studies within the IMI DIRECT Consortium 93%
Similar papers in this journal
- Factors associated with therapeutic inertia in individuals with type 2 diabetes mellitus started on basal insulin 95%
- Glycemic outcomes of a family-focused intervention for adults with type 2 diabetes: Main, mediated, and subgroup effects from the FAMS 2.0 RCT 91%
- Data-driven subtypes of type 2 diabetes mellitus and risk of dementia, stroke, and brain structural changes in the UK Biobank 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.